BriaCell Therapeutics Corp (TSE:BCT)
TSX:BCT
Holding TSE:BCT?
Track your performance easily

BriaCell Therapeutics (BCT) Financial Statements

46 Followers

BriaCell Therapeutics Financial Overview

BriaCell Therapeutics's market cap is currently ―. The company's EPS TTM is C$-1.576; its P/E ratio is -0.63; BriaCell Therapeutics is scheduled to report earnings on December 11, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 12.95M$ 1.69M$ -11.33M$ 5.96M$ -2.42M
EBITDA$ 13.02M$ 1.70M$ -11.33M$ 5.96M$ -2.41M
Net Income Common Stockholders$ 13.09M$ 1.72M$ -11.29M$ 6.00M$ -2.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 862.09K$ 935.69K$ 6.24M$ 13.65M$ 21.25M
Total Assets$ 5.87M$ 6.20M$ 12.23M$ 18.62M$ 27.16M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -862.09K$ -935.69K$ -6.24M$ -13.65M$ -21.25M
Total Liabilities$ 8.56M$ 12.44M$ 20.55M$ 16.10M$ 30.94M
Stockholders Equity$ -2.38M$ -5.97M$ -8.07M$ 2.72M$ -3.78M
Cash Flow-
Free Cash Flow$ -11.76M$ -5.08M$ -7.40M$ -7.61M$ -10.92M
Operating Cash Flow$ -11.30M$ -5.08M$ -7.40M$ -7.61M$ -10.92M
Investing Cash Flow$ -681.80K$ -225.00K---
Financing Cash Flow$ 4.46M---$ 4.00M
Currency in USD

BriaCell Therapeutics Earnings and Revenue History

BriaCell Therapeutics Debt to Assets

BriaCell Therapeutics Cash Flow

BriaCell Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis